Please ensure Javascript is enabled for purposes of website accessibility Methylsynephrine in Dietary Supplements

My Cart

Close

science nutrition blog

science nutrition <strong>blog</strong>

Methylsynephrine: FDA Actions on Dietary Supplements

April 17, 2018 - Admin

The U.S. Food and Drug Administration (FDA) recently took significant action by sending warning letters to seven companies after identifying the stimulant methylsynephrine as an ingredient in their dietary supplements. Methylsynephrine, also known as Oxilofrine and p-hydroxyephendrine, is a substance that raises serious concerns regarding supplement regulation. According to the 1994 Dietary Supplement Health and Education Act, the FDA has the authority to remove products from the market if they are deemed unsafe supplements or if their labeling is false or misleading. Methylsynephrine is listed on the World Anti Doping Agency's banned substances list and does not meet the definition of a dietary ingredient.

The presence of methylsynephrine in supplements poses significant risks to consumer safety, as it is considered an illegal supplement. The FDA findings underscore the critical need for robust supplement regulation to protect consumers from unsafe supplements. This regulatory action emphasizes the importance of ensuring that all dietary supplements on the market are safe and accurately labeled.

For those seeking safe alternatives, bitter orange supplement extracts offer p-synephrine, a legal and natural source of synephrine. Unlike methylsynephrine supplements, p-synephrine does not increase heart rate or blood pressure (fda.gov/Food/DietarySupplements/ProductsIngredients/ucm493282.htm), making it a safer choice for consumers. The FDA's actions highlight the ongoing need for vigilance in the supplement industry to maintain the highest standards of consumer safety and product integrity.

Choosing safe and effective dietary supplements is crucial for maintaining health and wellness. Consumers should be aware of the following key points regarding methylsynephrine and supplement regulation to make informed decisions:

  • Methylsynephrine is a banned substance and not recognized as a dietary ingredient, leading to its classification as an illegal supplement.
  • The FDA has the authority to act against unsafe supplements and misleading labeling, ensuring consumer protection.
  • Consumer safety is paramount, necessitating strict supplement regulation to prevent the distribution of unsafe supplements.
  • Legal alternatives like p-synephrine from bitter orange extracts are available and offer a safer option for those seeking stimulant effects without the associated risks.
  • Ongoing FDA actions are crucial to ensuring safe and effective dietary supplements, reinforcing the importance of regulatory oversight in the industry.

The FDA's proactive approach in addressing the presence of methylsynephrine in dietary supplements demonstrates the agency's commitment to safeguarding public health. By continually monitoring and regulating the supplement industry, the FDA helps to ensure that consumers have access to safe, high-quality products. It's essential for both consumers and manufacturers to stay informed about the latest FDA findings and actions to maintain compliance and prioritize safety in dietary supplement choices.